Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
TRANSITION Add to My Watchlist (NSDQ: TTHI) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Transition 2.53 +0.01 (+0.40%) 46,321
220-101 College St
Toronto, ON M5G 1L7 CN
(416) 260-7770
(416) 260-2886 fax
www.transitiontherapeutics.com
CEO Dr. Tony F. Cruz
Auditor PricewaterhouseCoopers LLP
Exchange Traded NQ
ISIN Number CA8937162094
CIK Number 1399250
NAICS Code 325410
Business Summary
A product-focused biopharmaceutical company developing therapeutics for disease indications with large markets.
Number of Employees 28
Share Fundamentals
Market Cap 58.74M
Shares Outstanding 23.22M
Float N/A
Short Interest 1.31K
Financial Strength
Revenue (TTM) $2,164,000
Earnings (TTM) -$19,266,000
Quick Ratio 5.8:1
Current Ratio 5.9:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Real Time Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs